Of mice and molecular mimicry: Modeling autoimmune hepatitis

Hepatology

Volumn 48, Issue 3, 2008, Pages 1013-1015

  Bowen, David G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOCHROME P450 2D6; DNA VACCINE; EPITOPE; LIVER KIDNEY MICROSOME 1 ANTIBODY; PLASMID DNA;

ADENOVIRUS; ANTIBODY PRODUCTION; AUTOIMMUNE HEPATITIS; CELL INFILTRATION; CYTOMEGALOVIRUS; DISEASE EXACERBATION; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; IMMUNOLOGICAL TOLERANCE; KIDNEY MICROSOME; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SHORT SURVEY; VIRUS INFECTION; VIRUS PATHOGENESIS; WILD TYPE;

EID: 51349167400     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22529     Document Type: Short Survey

References (21)

1. Rose NR, Mackay IR. Molecular mimicry: A critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000;57:542-551.
2. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991;88:1370-1378.
3. Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, et al. Cytochrome P4502D6(193-212): A new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 2003;170:1481-1489.
4. Herkel J, Heidrich B, Nieraad N, Wies I, Rother M, Lohse AW. Fine specificity of autoantibodies to soluble liver antigen and liver/ pancreas. HEPATOLOGY 2002;35:403-408.
5. Kita H, Mackay IR, Van De Water J, Gershwin ME. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001;120:1485-1501.
6. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3: 51-62.
7. Bowen DG, McCaughan GW, Bertolino, P. Intrahepatic immunity: A tale of two sites? Trends Immunol 2005;26:512-517.
8. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993;178:1541-1554.
9. Bertolino P, Heath WR, Hardy CL, Morahan G, Miller JF. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol 1995;25:1932-1942.
10. Limmer A, Sacher T, Alferink J, Kretschmar M, Schonrich G, Nichterlein T, et al. Failure to induce organ-specific autoimmunity by breaking of tolerance: Importance of the microenvironment. Eur J Immunol 1998;28: 2395-2406.
11. Voehringer D, Blaser C, Grawitz AB, Chisari FV, Buerki K, Pircher H. Break of T cell ignorance to a viral antigen in the liver induces hepatitis, J Immunol 2000; 165:2415-2422.
12. Lohse AW, Manns M, Dienes HP, Meyer zum Buschenfelde KH, Cohen IR. Experimental autoimmune hepatitis: Disease induction, time course and T-cell reactivity. HEPATOLOGY 1990;11:24-30.
13. Lohse AW, Meyer zurn Buschenfelde KH. Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific inummosuppression. Clin Exp Immunol 1993;94:163-167.
14. Djilali-Saiah I, Lapierre P, Vittozi S, Alvarez F. DNA vaccination breaks tolerance for a neo-self antigen in liver: A transgenic murine model of autoimmune hepatitis. J Immunol 2002;169:4889-4896.
15. Lapierre P, Djilali-Saa I, Vitozzi S, Alvarez F. A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens. HEPATOLOGY 2004;39:1066-1074.
16. Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection, J Exp Med 2008;205:1409-1422.
17. Manns MP, Vogel A. Autoimmune hepatitis, from mechanisms to therapy. HEPATOLOGY 2006;43:S132-S144.
18. Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Barisal S, Longhi MS, et al. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 2006; 130:868-882.
19. Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, et al. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. HEPATOLOGY 2007;46:472-484.
20. Lapierre P, Beland K, Djilali-Saiah I, Alvarez F. Type 2 autoimmune hepatitis murine model: The influence of genetic background in disease development. J Autoimmun 2006;26:82-89.
21. Esteban LM, Tsoutsman T, Jordan MA, Roach D, Poulton LD, Brooks A, et al. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J Immunol 2003;171:2873-2878.